Journal article
Endoplasmic reticulum aminopeptidase 1 (ERAP1) plays a critical role in determining the length and sequence of peptides bound and presented by HLA-B27
- Abstract:
-
Objective. HLA-B27 and ERAP1 are the two strongest predisposing genetic factors to Ankylosing Spondylitis (AS). A key aminopeptidase in MHC class I presentation, ERAP1 potentially contributes to AS pathogenesis through altering HLA-B27 peptide presentation. We studied the effects of ERAP1 on the HLA-B27 peptide repertoire and peptide presentation to Cytotoxic T lymphocytes (CTLs).
Methods. ERAP1-silenced and -competent HeLa.B27/C1R.B27 cells were isotope labeled, mixed, lysed and then immuno-precipitated using W6/32 or ME1. Peptides bound to HLA-B27 were eluted and analyzed by tandem Mass Spectrometry. Selected peptides were synthesized and tested for HLA-B27 binding ability. The effect of ERAP1 silencing/mutation on presentation of an immunodominant viral HLA-B27 epitope, KK10, to CTL was also studied.
Results. In both HeLa.B27 and C1R.B27 cells, the proportion of 9mer HLA-B27-bound peptides was decreased by ERAP1 silencing, whereas the percentage of longer peptides (11-13mers) increased. Surprisingly, following ERAP1 silencing, C-terminally extended peptides were readily identified. These were better able to bind to HLA-B27 than N-terminally extended peptides lacking a P2 Arginine. In both HeLa.B27 and mouse fibroblasts expressing HLA-B27, the absence of ERAP1 reduced recognition by HLA-B27-restricted KK10-specific CTLs following recombinant vaccinia viral infection or transfection with minigenes expressing KK10 precursors. Lastly, an AS protective variant, K528R-ERAP1, reduced KK10 CTL recognition following extended-KK10 minigene transfection compared to WT-ERAP1.
Conclusion. Our study shows that ERAP1 directly alters peptide binding and presentation by HLA-B27, supporting a pathogenic mechanism in AS. ERAP1 inhibition could potentially be used for treatment of AS and other ERAP1-associated diseases. © 2013 American College of Rheumatology.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, pdf, 644.1KB, Terms of use)
-
- Publisher copy:
- 10.1002/art.38249
Authors
Contributors
- Institution:
- University of Oxford
- Division:
- MSD
- Department:
- NDM
- Role:
- Owner
- Funding agency for:
- Reeves, E
- Elliott, T
- James, E
- Grant:
- A10601
- A10601
- A10601
- Funding agency for:
- Kollnberger, S
- Kessler, B
- Bowness, P
- Publisher:
- Wiley-Blackwell
- Journal:
- Arthritis and Rheumatism More from this journal
- Publication date:
- 2016-01-01
- DOI:
- EISSN:
-
1529-0131
- ISSN:
-
0004-3591
- Language:
-
English
- Keywords:
- Subjects:
- UUID:
-
uuid:cb7e8621-7cb2-4c3a-b4bf-ac89ca9d7d6e
- Local pid:
-
ora:7608
- Deposit date:
-
2013-12-02
- ARK identifier:
Terms of use
- Copyright holder:
- American College of Rheumatology
- Copyright date:
- 2013
- Notes:
- The full text of the principal article cannot currently be made available via ORA due to publisher copyright. You may be able to access a copy of the article through the publisher's website by using the link above.
If you are the owner of this record, you can report an update to it here: Report update to this record